The CataloniaBio & HealthTech website (cataloniabio.org) has received more than 96,000 visits during first half of 2018, 68% of Spain and 32% international. 

Communication is a strategic focal point for the association, which has several channels aimed at members and stakeholders (investors, entrepeneurs, researchers, journalists...). These channels are the website, social media (more than 25,000 followers on Twitter and LinkedIn and 1,900 views on YouTube), the newsletter with corporate and member news (monthly), the paper review (delivered at the CataloniaBioHT Gala Dinner and BBQ) and internal communications called Weekly Bullets

On the other hand ...


Jordi Naval is the new CEO of Biocat, an organisation created in 2006 by the Government of Catalonia to promote the healthcare and life sciences ecosystem along with other actors such as ACCIÓ and the association of companies CataloniaBio & HealthTech.

He is now taking over the position that was left vacant a year ago by the previous CEO Albert Barberà, current Director General for Research and Innovation in Health.

Jordi Naval has a degree in Pharmacy from the University of Barcelona (UB) and in Biochemistry from the Autonomous University of Barcelona (UAB). He has helped launch several start-ups like ...


The Research Centre for Biomedical Engineering (CREB) of the Polytechnic University of Catalonia (UPC), a CataloniaBio & HealthTech member, inaugurated its new facilities on 6 July with a day of conferences and visits from researchers and members of the UPC governing bodies.

Most of the research groups at the CREB have moved to the offices and laboratories on the fourth floor at the Barcelona School of Industrial Engineering. Previously, they were located in several different buildings at the university.

The CREB has more than 25 years of experience in technology transfer, holds 27 patents and 5 to out-license, and has ...


Devicare, member of CataloniaBio & HealthTech, is moving forward in its international expansion by closing licensing and distribution agreements in Argentina, Uruguay and Peru. Various pharmaceutical companies will introduce the products from the Lit-Control® brand to improve the urinary healthcare of the residents of Latin America. The company had previously announced its entry into Mexico and Colombia.

“These agreements with leading urological pharmaceutical companies confirm our scientific work, our clinical data, as well as the commercial interest in our products” remarks Rosendo Garganta, co-Founder and CEO of the company located at the UAB Research Park.

The company expects to end ...


Dr Daniel López Serrano of the National Centre for Biotechnology (CNB) and Prof Rubén Martín of the Institute of Chemical Research of Catalonia (ICIQ) have won the XIII Banco Sabadell Award for Biomedical Research and II Banco Sabadell Foundation Award for Science and Engineering, respectively.

Biochemist Dr López Serrano has received the recognition for his innovative contribution in the field of bacterial resistance to antibiotics, a topic which is relevant in terms of biomedicine and sanitation on a global scale. 

On the other hand, Prof. Martín has won the award for his innovative and creative vision of chemical ...